Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

Lille’s Macopharma uses cell therapy to fight diabetes

07 Apr 2015 | Health Nutrition, A region on the move

Lille-based Macopharma, a major specialist player in pharmaceuticals, has developed an automated culturing system to optimize preservation of pancreatic islets—cells that play a key role in treating diabetes.

Macopharma innovation - Health- Lille Region

Prisma—a pioneer in diabetes therapy

Macopharma’s revolutionary Prisma (Pancreatic Islet System Automate unit) breaks new ground in biotherapy.  The product of four years of R&D, this new machine automatically preserves pancreatic islets, the insulin-secreting cells that are used to treat patients with type 1 diabetes.

Patented technology, bold commercial roll-out

Prisma uses three patented systems: a disposable medical device, a cell chamber that preserves the islets, and a specially optimized cell culture medium. “We’ve already deployed Prisma at three major cell therapy centers,” says Bruno Delorme, head of Biotherapy R&D at Macopharma. “These are Lille’s University Hospital Center (CHRU), our co-developer, plus units in Switzerland and in Sweden.

 

 

Source: Les Echos, Nicole Buyse

 

 

Back to news

News

Ÿnsect is setting up business in Amiens and investing more than €150M

The production of insects for the agri-food industry is thriving. The insect-derived protein production specialist, Ÿnsect, has decided to open its first industrial unit in Amiens. This estimated €150-180...

Renault Maubeuge: the most competitive plant in France

Renault Maubeuge is one of Renault’s top performing sites in France. €450M will be invested there over the next 5 years. A strategic choice that solidifies the Hauts-de-France Region’s 1st place position in...

All news